Cite
HARVARD Citation
Kim, M. et al. (2020). Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study. Gut. 69 (12), pp. 2214-2222. [Online].